Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of dimethylamine 4-O-acetyl inula lineariifolia lactone A and salt thereof in preparation of medicine for treating chronic renal failure

A chronic, drug-based technology, applied in the field of medicine, that can solve problems such as shortages

Pending Publication Date: 2021-09-17
SHANXI ZHENDONG LEADING BIOTECH CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Commonly used TCM syndrome differentiation treatment plus Western medicine symptomatic treatment, clinically there is a shortage of drugs to improve kidney function, reduce proteinuria, and delay kidney damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of dimethylamine 4-O-acetyl inula lineariifolia lactone A and salt thereof in preparation of medicine for treating chronic renal failure
  • Application of dimethylamine 4-O-acetyl inula lineariifolia lactone A and salt thereof in preparation of medicine for treating chronic renal failure
  • Application of dimethylamine 4-O-acetyl inula lineariifolia lactone A and salt thereof in preparation of medicine for treating chronic renal failure

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1 Preparation of Inula Lactone A

[0037] Pulverize 50Kg of dried whole plant of Inula lanceolata, extract 2 times with 750L of 90% ethanol for 2 hours each time, combine the extracts, and concentrate the extracts under reduced pressure into a fluid extract, which is equivalent to 1ml containing the leaves. Inula flower 1.0g, the liquid extract was diluted with 50L of water, and extracted 5 times with 50L of petroleum ether each time to obtain the petroleum ether fraction. The petroleum ether fraction was applied to silica gel column chromatography, eluted with petroleum ether / ethyl acetate system gradient with a volume ratio of 100:0 to 1:1, detected by thin-layer chromatography, and collected. Fraction, and then subjected to C18 reverse-phase column chromatography, eluted with methanol / water with a weight ratio of 50:100-70:100, and detected by thin-layer chromatography to obtain 45.3g of pure inula lactone A. .

[0038] The obtained compound was first measu...

Embodiment 2

[0039] The preparation of embodiment two 4-O-acetyl basal leaf inula lactone A

[0040] Take the above-mentioned inula lactone A (10.0g, 0.027mol, 1.0eq), p-dimethylaminopyridine (DMAP) (4.0g, 0.033mol, 1.2eq) and acetic anhydride (Ac2O) (3.34g, 0.033 mol, 1.2eq) was placed in a 500mL eggplant-shaped flask, 200mL of anhydrous dichloromethane (CH2Cl2) was added, and the mixture was stirred at room temperature for 12h. The reaction was monitored by thin-layer chromatography. After the reaction of the raw materials was completed, 200 mL of water was added to quench, and the water layer was discarded. The organic layer was extracted with 100 mL of water, and the water layer was discarded. Repeat this step until the organic layer No DMAP was detected (TLC method), the organic layer was washed with saturated brine, dried over anhydrous sodium sulfate (Na2SO4), concentrated under reduced pressure below 40°C, and subjected to silica gel column chromatography with a volume ratio of 15:...

Embodiment 3

[0042] The preparation of embodiment three dimethylamine 4-O-acetyl basal leaf inula lactone A

[0043] Take the above-mentioned 4-O-acetyl basal leaf inula lactone A (10.0g, 0.024mol, 1.0eq) and dimethylamine hydrochloride (CH3NHCH3·HCl) (3.0g, 0.037mol, 1.5eq) in 500mL In the eggplant-shaped flask, add 200 mL of ethanol to dissolve, place the reaction flask in a low-temperature cooling tank, and slowly add triethylamine (NEt) dropwise at 0 °C. 3 ) (5.1mL, 0.037mol, 1.5eq), then the reaction system was slowly raised to room temperature (25°C), stirred, and the reaction was monitored by thin layer chromatography. After 4h, the reaction of the raw materials was complete, and the solvent was evaporated under reduced pressure to obtain the crude product , the crude product was dissolved in 200 mL of dichloromethane, and 100 mL of water was added for extraction. The aqueous layer was discarded, and this step was repeated until no dimethylamine hydrochloride was detected in the org...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicines, in particular to medical application of dimethylamine 4-O-acetyl inula lineariifolia lactone A and salt thereof. The dimethylamine 4-O-acetyl inula lineariifolia lactone A and the salt thereof disclosed by the invention can be used for preparing a medicine for treating chronic renal failure.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the medicinal use of a kind of dimethylamine 4-O-acetyl basal inula lactone A and a salt thereof. Background technique [0002] Chronic renal failure refers to a clinical syndrome composed of decreased glomerular filtration rate caused by various chronic kidney diseases and related metabolic disorders and clinical symptoms. The clinical manifestations are decreased glomerular filtration rate, retention of metabolites, imbalance of water, electrolyte and acid-base balance, and damage to various systems. Slow progressive renal insufficiency and even failure due to nephron damage is a common disease with poor prognosis. The end-stage of chronic renal failure is called end-stage renal disease, also known as uremia. Current treatments for chronic renal failure include relieving symptoms, reducing complications, and delaying the progression of renal failure. Traditional Chinese med...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/365A61P13/12C07D307/93C07C57/15C07C51/41
CPCA61K31/365A61P13/12C07D307/93C07C57/15C07C51/412
Inventor 张卫东杨保华游蓉丽李昆
Owner SHANXI ZHENDONG LEADING BIOTECH CO LTD